文献速递神经康复

个体化经颅直流电刺激对比伪刺激用于亚急性卒中上肢康复的可行性与初步试验

Patient-Tailored Transcranial Direct Current Stimulation Versus Sham for Upper-Extremity Rehabilitation in Subacute Stroke Patients: A Feasibility and Pilot Trial.
PubMed 文献 · Neurorehabil Neural Repair · 2026-01-18

该随机双盲可行性与初步临床试验纳入24例亚急性缺血性卒中上肢障碍患者,比较个体化阳极经颅直流电刺激(TDCS)与伪刺激在4周上肢康复中的效果。两组依从性中位数分别为95.8%和100%,无严重不良事件。

要点

  • 个体化阳极TDCS靶向患侧M1-HAND,可能促进亚急性卒中上肢运动恢复。
  • 干预结束时FMA-UE改善真TDCS组显著优于伪刺激组,但12周随访差异减小。
  • 试验框架临床可行,依从性高且无严重不良事件,支持未来大样本研究。

核心结论

  • 个体化阳极TDCS作用于患侧M1-HAND可能较伪刺激促进亚急性卒中上肢障碍恢复,但12周随访时组间差异减小。

研究设计与样本

  • 随机双盲可行性与初步临床试验,纳入亚急性缺血性卒中伴上肢障碍患者24例,真TDCS组12例(平均年龄63岁),伪刺激组12例(平均年龄68岁)。
  • 干预为在每周3次、持续4周的上肢康复期间给予阳极TDCS或伪刺激,电极位置基于电场建模个体化优化并靶向患侧M1-HAND。

主要发现

  • 12周随访时组间差异减小。
  • 真TDCS组与伪刺激组依从性中位数分别为95.8%和100%,无严重不良事件。

关键数值与推荐

  • 主要结局为干预结束时和12周随访时的FMA-UE评分。

临床怎么用

  • 个体化阳极TDCS靶向患侧M1-HAND可作为亚急性卒中上肢康复的可行辅助手段,需注意12周随访时获益减小。
  • 该试验提供了优化个体化TDCS方案的可行框架,支持未来按上肢障碍程度分层的大规模研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundStroke is a leading cause of upper-extremity (UE) motor impairments worldwide. Transcranial direct current stimulation (TDCS) may enhance UE recovery, but response variability remains a challenge.ObjectiveThis randomized, double-blinded feasibility and pilot clinical trial evaluated effects of patient-tailored TDCS versus sham on UE recovery in subacute stroke.MethodsPatients with subacute ischemic stroke and UE impairment were randomized to receive either anodal TDCS or sham stimulation, during UE rehabilitation 3 times weekly for 4 weeks. Electrode placement was patient-tailored and optimized using electric field modeling and targeted the ipsilesional primary motor hand area (M1-HAND). Primary outcome was Fugl-Meyer Assessment of UE (FMA-UE) score at end-of-intervention (EOT) and 12-weeks follow-up. Feasibility and exploratory clinical outcomes were also assessed.Results24 participants were randomized into real (n = 12, mean age 63 years) and sham TDCS (n = 12, mean age 68 years). FMA-UE improved at EOT in both groups, but improvement was significantly larger in the real TDCS group (mean difference 4.5 points, 95% confidence interval (CI) -5.34-14.31, P = .011). The differences diminished at 12-week follow-up. Median compliance was 95.8 and 100%, for real- and sham-TDCS groups, respectively, with no severe adverse events.ConclusionsPatient-tailored anodal TDCS over the ipsilesional M1-HAND may boost recovery of UE impairment in subacute stroke versus sham TDCS. This trial identified a clinically feasible framework for optimizing protocols of patient-tailored TDCS for larger-scale stroke trials. Despite the complex trial setup, the favorable safety profile supports future large-scale studies with improved stratification by UE impairment.

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Kolmos M, Johansen KL, Olsen MH, et al. Patient-Tailored Transcranial Direct Current Stimulation Versus Sham for Upper-Extremity Rehabilitation in Subacute Stroke Patients: A Feasibility and Pilot Trial. Neurorehabil Neural Repair. 2026. PMID: 41549053. doi:10.1177/15459683251395731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。